Dose Escalation of Velcade Daily Dose in Patients With Solid Tumors
Clinical trial NCT02220049 · COMPLETED
Trial details
- NCT number
- NCT02220049
- Sponsor
- Gustave Roussy, Cancer Campus, Grand Paris
- Status
- COMPLETED
- Phase
- Phase 1
- Study type
- INTERVENTIONAL
- Start date
- 2010-12-01
- Primary completion
- 2013-11-01
- Enrollment
- 18
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.